Mindbloom Launches ‘Mastermind Series’

December 5, 2023

NRx Pharmaceuticals Plans to Spin Off Ketamine-Focused Company

November 16, 2023

FDA: At-Home Ketamine Treatments Pose Serious Risks, Lack Supervision

November 14, 2023

Choose Your Horizon Raises $215,000 to Expand At-Home Ketamine Therapy

November 13, 2023

ATMA Announces Collaboration with Aviva Fohrer to Develop KAT Protocols for Addiction Treatment

November 8, 2023

AANA, APNA Issue Joint Statement on Ketamine Infusion Therapy for Psychiatric Disorders

November 4, 2023